Legend-Related Investment Firm Joins Funding Round In Gene Therapy Start-Up Exegenesis

Gene therapy start-up Exegenesis Bio Inc. has completed tens of millions of USD in a funding round led by K2 venture partners, one of venture capital units of Chinese investment firm K2VC, according to Chinese media outlet 36Kr. China’s investment firm Kaitai Capital and Legend Holdings’s subsidiary Legend Star also participated in the funding round. […]

Legend-Related Investment Firm Joins Funding Round In Gene Therapy Start-Up Exegenesis comes originally from China Money Network. All Rights Reserved.

Read the original article: China Money Network